These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6601112)

  • 21. Cross-reactivity of Trichomonas in cervical p16INK4a immunocytochemistry is dependent on antibody, not antigen.
    Ridder R; Trunk MJ; Negri G
    Diagn Cytopathol; 2006 Jul; 34(7):512-4; author reply 515. PubMed ID: 16783782
    [No Abstract]   [Full Text] [Related]  

  • 22. Identification of Trichomonas vaginalis alpha-actinin as the most common immunogen recognized by sera of women exposed to the parasite.
    Addis MF; Rappelli P; Pinto De Andrade AM; Rita FM; Colombo MM; Cappuccinelli P; Fiori PL
    J Infect Dis; 1999 Nov; 180(5):1727-30. PubMed ID: 10515842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of Trichomonas vaginalis antigen in women by enzyme immunoassay.
    Yule A; Gellan MC; Oriel JD; Ackers JP
    J Clin Pathol; 1987 May; 40(5):566-8. PubMed ID: 3495554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzyme linked immunosorbent assay for detecting antibody to Trichomonas vaginalis: use of whole cells and aqueous extract as antigen.
    Alderete JF
    Br J Vener Dis; 1984 Jun; 60(3):164-70. PubMed ID: 6610453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoglobulin isotypes of anti-Trichomonas vaginalis antibodies in patients with vaginal trichomoniasis.
    Wos SM; Watt RM
    J Clin Microbiol; 1986 Nov; 24(5):790-5. PubMed ID: 3490492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A preliminary study on the relationship between Trichomonas vaginalis and cervical cancer in Egyptian women.
    Sayed el-Ahl SA; el-Wakil HS; Kamel NM; Mahmoud MS
    J Egypt Soc Parasitol; 2002 Apr; 32(1):167-78. PubMed ID: 12049252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trichomonas vaginalis infection activates cells through toll-like receptor 4.
    Zariffard MR; Harwani S; Novak RM; Graham PJ; Ji X; Spear GT
    Clin Immunol; 2004 Apr; 111(1):103-7. PubMed ID: 15093558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of a rapid antigen detection system for Trichomonas vaginalis infection.
    Miller GA; Klausner JD; Coates TJ; Meza R; Gaydos CA; Hardick J; Leon S; Caceres CF
    Clin Diagn Lab Immunol; 2003 Nov; 10(6):1157-8. PubMed ID: 14607884
    [No Abstract]   [Full Text] [Related]  

  • 29. Pathogenicity of Trichomonas vaginalis.
    Graves A; Gardner WA
    Clin Obstet Gynecol; 1993 Mar; 36(1):145-52. PubMed ID: 8435939
    [No Abstract]   [Full Text] [Related]  

  • 30. [Determination of trichomonal antigens by means of complement fixation].
    Iankov N; Baltova E; Ishev V; Angelova E
    Akush Ginekol (Sofiia); 1972; 11(5):450-2. PubMed ID: 4539896
    [No Abstract]   [Full Text] [Related]  

  • 31. [Electrophoretic analysis of soluble antigens of a pathogenic isolate of Trichomonas vaginalis].
    Zhang Y; Wang Z; Wu L; Zhou X
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1998; 16(4):296-9. PubMed ID: 12078262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotherapeutic effect of the lactobacillus vaccine, Solco Trichovac, in trichomoniasis is not mediated by antibodies cross reacting with Trichomonas vaginalis.
    Gombosová A; Demes P; Valent M
    Genitourin Med; 1986 Apr; 62(2):107-10. PubMed ID: 3522408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trichomonas vaginalis and amplification of HIV-1 transmission.
    Sorvillo F; Kerndt P
    Lancet; 1998 Jan; 351(9097):213-4. PubMed ID: 9449891
    [No Abstract]   [Full Text] [Related]  

  • 34. [Detection of specific antibodies against Trichomonas vaginalis in human serum].
    Le Bách Quang ; Valent M; Jánoska A
    Bratisl Lek Listy; 1985 Feb; 83(2):129-39. PubMed ID: 3882195
    [No Abstract]   [Full Text] [Related]  

  • 35. Growth and life cycle of Trichomonas vaginalis and the mechanism of recurrence of Trichomonas vaginalis vaginitis.
    SHINOZUKA A
    J Jpn Obstet Gynecol Soc; 1955 Jan; 2(1):1-8. PubMed ID: 13252293
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of an enzyme-linked immunosorbent assay for the detection of antibody to Trichomonas vaginalis in sera and vaginal secretions.
    Street DA; Taylor-Robinson D; Ackers JP; Hanna NF; McMillan A
    Br J Vener Dis; 1982 Oct; 58(5):330-3. PubMed ID: 6982095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trichomonas vaginalis vaginitis.
    BAUM HC
    Med Clin North Am; 1958 Jan; 42(1):263-5. PubMed ID: 13540491
    [No Abstract]   [Full Text] [Related]  

  • 38. Monoclonal antibodies against Trichomonas vaginalis.
    Chang TH; Tsing SY; Tzeng S
    Hybridoma; 1986; 5(1):43-51. PubMed ID: 3514432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetics of immunoglobulin G, M, A and IgG subclass responses in experimental intravaginal trichomoniasis: prominence of IgG1 response.
    Yadav M; Gupta I; Malla N
    Parasite Immunol; 2005 Dec; 27(12):461-7. PubMed ID: 16255745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-trichomonad IgA antibodies in trichomoniasis before and after treatment.
    Sharma P; Malla N; Gupta I; Ganguly NK; Mahajan RC
    Folia Microbiol (Praha); 1991; 36(3):302-4. PubMed ID: 1841864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.